Côte d'Ivoire vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Côte d'Ivoire rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Europe (WHO region)
How they compare
Côte d'Ivoire currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Côte d'Ivoire's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 5 times across 17 shared years of data; in 2005 it was Europe (WHO region) ahead.
Côte d'Ivoire ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 2 and Europe (WHO region) in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 22.1% | 13.5% | Europe (WHO region) |
| 2010s | 60.3% | 58.6% | 1.7% | Côte d'Ivoire |
| 2020s | 98.4% | 93.8% | 4.6% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Europe (WHO region)?
- Côte d'Ivoire, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Europe (WHO region)?
- 10.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Europe (WHO region)?
- 17 years are reported by both, from 2005 to 2024.
- How do Côte d'Ivoire and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.